Quantum BioPharma Ltd. Ordinary Shares - Class B (Sub Voting) QNTM 深 滬
已收盤 08-08 16:00:00 美东时间
29.21
+3.200
+12.30%
華盛通- 最 高29.245
- 今 開27.81
- 成交量 21.71万股
- 最 低 26.94
- 昨 收 26.01
- 總市值 9997.71万
- 52周最高 38.25
- 市盈率 靜 --
- 換手率 6.34%
- 52周最低 2.70
- 委 比 95.50%
- 總股本 342.27万
- 歷史最高 909.5234
- 量 比 1.01
- 振 幅 8.86%
- 歷史最低 2.89
- 每 手 1
- 風險率 6.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients
Quantum BioPharma Ltd. has announced advancements in a joint clinical study with Massachusetts General Hospital (MGH) using a PET tracer to monitor myelin integrity and demyelination in MS patients. The tracer, developed by Dr. Pedro Brugarolas, showed the ability to detect lesion differences not visible via conventional MRI, offering potential as a biomarker for assessing Quantum's investigational drug, Lucid-21-302. The study was published in t...
08-08 12:00
Quantum BioPharma Q2 EPS $(3.23) Compared With $(0.08) YoY
Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(3.23) per share which missed the analyst consensus estimate of $(0.07) by 4514.29 percent. This is a 3937.5 percent decrease over losses of $(0.08) per share
08-07 19:48
Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt
Quantum BioPharma Ltd. reported strong second-quarter 2025 results, increasing current and total assets, eliminating debt, and seeing its stock price nearly triple. The Company advanced its multiple sclerosis drug, Lucid-MS, with successful Phase 1 safety studies and a joint PET scan study with Massachusetts General Hospital. Its unbuzzd product commercialized in the U.S. and is preparing for a $5 million raise and potential IPO. The Company also...
08-07 11:00
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)
Quantum BioPharma Ltd. announced that its Phase 1 trial of Lucid-MS, a novel neuroprotective compound for multiple sclerosis, showed no safety concerns in healthy participants. The company plans to advance clinical development and initiate efficacy trials in MS patients. Lucid-MS is a first-in-class, non-immunomodulatory compound designed to prevent myelin degradation, a hallmark of MS. The successful trial supports Quantum BioPharma's progress t...
08-05 11:34
Quantum BioPharma Pursues Legal Action Over Alleged Stock Manipulation
Quantum Biopharma ( ($TSE:QNTM) ) has provided an update. On August 4, 2025, Qu...
08-04 19:57
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
Quantum BioPharma Ltd. has filed a legal memorandum opposing a motion by CIBC and RBC to dismiss its amended complaint alleging market manipulation between January 1, 2020, and August 15, 2024. The lawsuit claims the banks used "spoofing" techniques to depress the company's stock price, seeking over $700 million in damages. Quantum has posted relevant legal documents on its website and retains no financial burden for the case, handled on a contin...
08-04 11:33
Quantum BioPharma’s Unbuzzd Wellness Launches $5M Capital Raise
The latest announcement is out from Quantum Biopharma ( ($TSE:QNTM) ). On July ...
07-31 19:56
Quantum BioPharma-Backed Unbuzzd Launches $5M Reg D Offering With Crypto Option, Retains 25% Stake Until $1B Valuation Ahead of Potential IPO
Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced that Unbuzzd Wellness
07-31 19:26
Quantum BioPharma Makes Strategic Investment in GameStop
Quantum Biopharma ( ($TSE:QNTM) ) has provided an update. On July 22, 2025, Qua...
07-22 19:28
Quantum BioPharma Makes Strategic Investment in GameStop Corp.
Quantum BioPharma Ltd. announced the purchase of 2,000 shares of GameStop Corp. as a strategic investment, aligning with its commitment to combat market corruption and enhance shareholder value. The company has been actively fighting market manipulation, including legal actions against several financial institutions alleges stock price manipulation. Additionally, the company is advancing its Multiple Sclerosis treatment, Lucid-MS, and plans to de...
07-22 11:00
